EUR UROL ONCOL - European Urology Oncology

Publications

  1. 2023
  2. Navigating Nomograms To Identify Prostate Cancer Patients for Lymph Node Dissection

    Karakiewicz, P. I., Incesu, R-B., Scheipner, L. & Graefen, M., 12.2023, In: EUR UROL ONCOL. 6, 6, p. 564-565 2 p.

    Research output: SCORING: Contribution to journalEditorialResearch

  3. Development and External Validation of a Machine Learning Model for Prediction of Lymph Node Metastasis in Patients with Prostate Cancer

    Sabbagh, A., Washington, S. L., Tilki, D., Hong, J. C., Feng, J., Valdes, G., Chen, M-H., Wu, J., Huland, H., Graefen, M., Wiegel, T., Böhmer, D., Cowan, J. E., Cooperberg, M., Feng, F. Y., Roach, M., Trock, B. J., Partin, A. W., D'Amico, A. V., Carroll, P. R. & Mohamad, O., 10.2023, In: EUR UROL ONCOL. 6, 5, p. 501-507 7 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  4. Prostate-specific Membrane Antigen-radioguided Surgery Facilitates Pelvic Lymph Node Dissection During Radical Prostatectomy for the Treatment of Locally Advanced Prostate Cancer with Regional Lymph Node Metastases

    Lunger, L., Steinhelfer, L., Korn, P., Eiber, M., Maurer, T., Büchler, J., Horn, T., Gschwend, J. E. & Heck, M. M., 02.2023, In: EUR UROL ONCOL. 6, 1, p. 95-98 4 p.

    Research output: SCORING: Contribution to journalShort publicationResearchpeer-review

  5. 2022
  6. EAU-EANM Consensus Statements on the Role of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Patients with Prostate Cancer and with Respect to [177Lu]Lu-PSMA Radioligand Therapy

    Fanti, S., Briganti, A., Emmett, L., Fizazi, K., Gillessen, S., Goffin, K., Hadaschik, B. A., Herrmann, K., Kunikowska, J., Maurer, T., MacLennan, S., Mottet, N., Murphy, D. G., Oprea-Lager, D. E., O'Sullivan, J. M., Oyen, W. J. G., Rouvière, O., Sartor, O., Stenzl, A., Van Poppel, H., Walz, J., Witjes, W. & Bjartell, A., 10.2022, In: EUR UROL ONCOL. 5, 5, p. 530-536 7 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  7. Diagnostic Performance of Prostate-specific Membrane Antigen Positron Emission Tomography-targeted biopsy for Detection of Clinically Significant Prostate Cancer:A Systematic Review and Meta-analysis

    Kawada, T., Yanagisawa, T., Rajwa, P., Sari Motlagh, R., Mostafaei, H., Quhal, F., Laukhtina, E., Aydh, A., König, F., Pallauf, M., Pradere, B., Ceci, F., Baltzer, P. A. T., Hacker, M., Rasul, S., Karakiewicz, P. I., Araki, M., Nasu, Y. & Shariat, S. F., 08.2022, In: EUR UROL ONCOL. 5, 4, p. 390-400 11 p.

    Research output: SCORING: Contribution to journalSCORING: Review articleResearch

  8. [68Ga]Ga-PSMA Versus [18F]PSMA Positron Emission Tomography/Computed Tomography in the Staging of Primary and Recurrent Prostate Cancer. A Systematic Review of the Literature

    Evangelista, L., Maurer, T., van der Poel, H., Alongi, F., Kunikowska, J., Laudicella, R., Fanti, S. & Hofman, M. S., 06.2022, In: EUR UROL ONCOL. 5, 3, p. 273-282 10 p.

    Research output: SCORING: Contribution to journalSCORING: Review articleResearch

  9. Definition and Impact on Oncologic Outcomes of Persistently Elevated Prostate-specific Antigen After Salvage Lymph Node Dissection for Node-only Recurrent Prostate Cancer After Radical Prostatectomy: Clinical Implications for Multimodal Therapy

    Bravi, C. A., Droghetti, M., Fossati, N., Gandaglia, G., Suardi, N., Mazzone, E., Cucchiara, V., Scuderi, S., Barletta, F., Schiavina, R., Osmonov, D., Juenemann, K-P., Boeri, L., Karnes, R. J., Kretschmer, A., Buchner, A., Stief, C., Hiester, A., Nini, A., Albers, P., Devos, G., Joniau, S., Van Poppel, H., Grubmüller, B., Shariat, S. F., Heidenreich, A., Pfister, D., Tilki, D., Graefen, M., Gill, I. S., Mottrie, A., Karakiewicz, P. I., Montorsi, F. & Briganti, A., 06.2022, In: EUR UROL ONCOL. 5, 3, p. 285-295 11 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  10. PROPOSe: A Real-life Prospective Study of Proclarix, a Novel Blood-based Test to Support Challenging Biopsy Decision-making in Prostate Cancer

    Steuber, T., Heidegger, I., Kafka, M., Roeder, M. A., Chun, F., Preisser, F., Palisaar, R-J., Hanske, J., Budaeus, L., Schiess, R., Keller, T., Semjonow, A., Hammerer, P., Manka, L., Ecke, T., Schwentner, C. & Ohlmann, C., 06.2022, In: EUR UROL ONCOL. 5, 3, p. 321-327 7 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  11. Pembrolizumab outperforms tyrosine kinase inhibitors as adjuvant treatment in patients with high-risk renal cell carcinoma after nephrectomy

    Laukhtina, E., Quhal, F., Mori, K., Sari Motlagh, R., Rajwa, P., Yanagisawa, T., Mostafaei, H., König, F., Aydh, A., Pradere, B., Enikeev, D., Karakiewicz, P. I., Schmidinger, M. & Shariat, S. F., 02.2022, In: EUR UROL ONCOL. 5, 1, p. 120-124 5 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  12. 2021
  13. A Systematic Review of the Emerging Role of Immune Checkpoint Inhibitors in Metastatic Castration-resistant Prostate Cancer: Will Combination Strategies Improve Efficacy?

    Heidegger, I., Necchi, A., Pircher, A., Tsaur, I., Marra, G., Kasivisvanathan, V., Kretschmer, A., Mathieu, R., Ceci, F., van den Bergh, R. C. N., Thibault, C., Tilki, D., Valerio, M., Surcel, C., Gandaglia, G. & EAU-YAU Prostate Cancer Working Group, 10.2021, In: EUR UROL ONCOL. 4, 5, p. 745-754 10 p.

    Research output: SCORING: Contribution to journalSCORING: Review articleResearch

  14. First-line Immunotherapy-based Combinations for Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-analysis

    Quhal, F., Mori, K., Bruchbacher, A., Resch, I., Mostafaei, H., Pradere, B., Schuettfort, V. M., Laukhtina, E., Egawa, S., Fajkovic, H., Remzi, M., Shariat, S. F. & Schmidinger, M., 10.2021, In: EUR UROL ONCOL. 4, 5, p. 755-765 11 p.

    Research output: SCORING: Contribution to journalSCORING: Review articleResearch

  15. Impact of Smoking Habit on Perioperative Morbidity in Patients Treated with Radical Cystectomy for Urothelial Bladder Cancer: A Systematic Review and Meta-analysis

    Tellini, R., Mari, A., Muto, G., Cacciamani, G. E., Ferro, M., Stangl-Kremser, J., Campi, R., Soria, F., Rink, M., Xylinas, E., Minervini, A., Briganti, A., Montorsi, F., Roupret, M., Shariat, S. F., Moschini, M. & European Association of Urology – Young Academic Urologists (EAU-YAU), Urothelial Carcinoma Working Group, 08.2021, In: EUR UROL ONCOL. 4, 4, p. 580-593 14 p.

    Research output: SCORING: Contribution to journalSCORING: Review articleResearch

  16. A Systematic Review of Focal Ablative Therapy for Clinically Localised Prostate Cancer in Comparison with Standard Management Options: Limitations of the Available Evidence and Recommendations for Clinical Practice and Further Research

    Bates, A. S., Ayers, J., Kostakopoulos, N., Lumsden, T., Schoots, I. G., Willemse, P-P. M., Yuan, Y., van den Bergh, R. C. N., Grummet, J. P., van der Poel, H. G., Rouvière, O., Moris, L., Cumberbatch, M. G., Lardas, M., Liew, M., Van den Broeck, T., Gandaglia, G., Fossati, N., Briers, E., De Santis, M., Fanti, S., Gillessen, S., Oprea-Lager, D. E., Ploussard, G., Henry, A. M., Tilki, D., van der Kwast, T. H., Wiegel, T., N'Dow, J., Mason, M. D., Cornford, P., Mottet, N. & Lam, T. B. L., 06.2021, In: EUR UROL ONCOL. 4, 3, p. 405-423 19 p.

    Research output: SCORING: Contribution to journalSCORING: Review articleResearch

  17. The Role of Magnetic Resonance Imaging and Positron Emission Tomography/Computed Tomography in the Primary Staging of Newly Diagnosed Prostate Cancer: A Systematic Review of the Literature

    Abrams-Pompe, R. S., Fanti, S., Schoots, I. G., Moore, C. M., Turkbey, B., Vickers, A. J., Walz, J., Steuber, T. & Eastham, J. A., 06.2021, In: EUR UROL ONCOL. 4, 3, p. 370-395 26 p.

    Research output: SCORING: Contribution to journalSCORING: Review articleResearch

  18. Use and Impact of Positron Emission Tomography/Computed Tomography Prior to Salvage Radiation Therapy in Men with Biochemical Recurrence After Radical Prostatectomy: A Scoping Review

    Valle, L., Shabsovich, D., de Meerleer, G., Maurer, T., Murphy, D. G., Nickols, N. G., Vapiwala, N., Calais, J. & Kishan, A. U., 06.2021, In: EUR UROL ONCOL. 4, 3, p. 339-355 17 p.

    Research output: SCORING: Contribution to journalSCORING: Review articleResearch

  19. 2020
  20. Cutting-edge Management of Muscle-invasive Bladder Cancer in 2020 and a Glimpse into the Future

    Vetterlein, M. W., Witjes, J. A., Loriot, Y., Giannarini, G., Albersen, M., Ribal, M. J., Rouprêt, M. & EAU Section of Oncological Urology (ESOU) Board, 12.2020, In: EUR UROL ONCOL. 3, 6, p. 789-801 13 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  21. Development and Validation of a Lookup Table for the Prediction of Metastatic Prostate Cancer According to Prostatic-specific Antigen Value, Clinical Tumor Stage, and Gleason Grade Groups

    Preisser, F., Bandini, M., Nazzani, S., Mazzone, E., Marchioni, M., Tian, Z., Chun, F. K. H., Saad, F., Briganti, A., Haese, A., Montorsi, F., Huland, H., Graefen, M., Tilki, D. & Karakiewicz, P. I., 10.2020, In: EUR UROL ONCOL. 3, 5, p. 631-639 9 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  22. Management of Patients with Node-positive Prostate Cancer at Radical Prostatectomy and Pelvic Lymph Node Dissection: A Systematic Review

    Marra, G., Valerio, M., Heidegger, I., Tsaur, I., Mathieu, R., Ceci, F., Ploussard, G., van den Bergh, R. C. N., Kretschmer, A., Thibault, C., Ost, P., Tilki, D., Kasivisvanathan, V., Moschini, M., Sanchez-Salas, R., Gontero, P., Karnes, R. J., Montorsi, F., Gandaglia, G. & EAU-YAU Prostate Cancer Working Group, 10.2020, In: EUR UROL ONCOL. 3, 5, p. 565-581 17 p.

    Research output: SCORING: Contribution to journalSCORING: Review articleResearch

  23. 2019
  24. Multilevel Analysis of Readmissions After Radical Cystectomy for Bladder Cancer in the USA: Does the Hospital Make a Difference?

    Cole, A. P., Ramaswamy, A., Harmouch, S., Fletcher, S. A., Gild, P., Sun, M., Lipsitz, S. R., Chiang, H. A., Haider, A. H., Preston, M. A., Kibel, A. S. & Trinh, Q-D., 07.2019, In: EUR UROL ONCOL. 2, 4, p. 349-354 6 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  25. Regression Discontinuity Analysis of Salvage Radiotherapy in Prostate Cancer

    Gild, P., Pompe, R. S., Seisen, T., Keeley, J., Tang, H. J., Bossi, A., Tilki, D., Menon, M. & Abdollah, F., 2019, In: EUR UROL ONCOL.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  26. 2018
  27. Effectiveness of Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer in the Current Real World Setting in the USA

    Hanna, N., Trinh, Q-D., Seisen, T., Vetterlein, M. W., Sammon, J., Preston, M. A., Lipsitz, S. R., Bellmunt, J., Menon, M., Choueiri, T. K. & Abdollah, F., 05.2018, In: EUR UROL ONCOL. 1, 1, p. 83-90

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review